Tuesday, 31 March 2015

World first study reveals antibodies that may trigger psychosis in children






Credit: Robert Kraft/public domain

A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in psychiatric illness.



Antibodies defend the body against bacterial, viral, and other invaders but sometimes the body makes that attack healthy cells. In these cases, develop. These include conditions such as multiple sclerosis (MS), rheumatoid arthritis and Type 1 diabetes.


This 'immune hypothesis' is supported by new work colleagues in the current issue of Biological Psychiatry


Researchers from the Kids Research Institute at the Children's Hospital, Westmead, and the University of Sydney detected antibodies to the dopamine D2 receptor or the N-methyl-D-aspartate (NMDA) glutamate receptor among eight out of 43 children experiencing their first episode of psychosis, but no such antibodies in healthy children.


Both are key neural signaling proteins previously been implicated in psychosis.


"The antibodies we have detected in children having a first episode of acute psychosis suggest there is a distinct subgroup for whom autoimmunity plays a role in their illness," says the University of Sydney's Dr Fabienne Brilot, the senior author on the paper and Head of the Neuroimmunology Group at The Children's Hospital at Westmead in Sydney.


"The finding suggests that better interventions are possible, providing hope that major disability can be prevented for the subset of children experiencing acute psychosis with antibodies," Brilot adds.


Dopamine is a chemical messenger aiding the transmission of signals in the brain and other areas of the body. Regulating its actions plays a crucial role in mental and physical health.


Dopamine acts on receptors tailored specifically for it. The dopamine-2 receptor (D2R) is one of five subtypes of mammalian dopamine. Increasing knowledge of the roles of dopamine receptor subtypes raises the hope that more selective drugs will be developed.


Abnormalities in dopaminergic neurotransmission play a key role in the pathogenesis of psychosis. Many drugs affect dopamine transmission directly by either blocking or stimulating its receptors.


Many antipsychotics show varying affinities for the different but blockade of the dopamine-2 receptor (D2R) specifically has proved to be indispensable in the clinical management of psychosis.


While less well established than , it is also likely that glutamatergic dysfunction also plays a role in psychotic disease.


This suggests that specific pathologies and processes affecting D2R and the glutamatergic N-methyl-D-aspartate receptor (NMDAR) could define biological subgroups and may be involved in the pathogenesis of and other psychiatric illnesses such as schizophrenia.


"There is a pressing need in psychiatry to establish biologically based disease subtypes, which might allow for more specific diagnosis and effective intervention," says Dr Brilot.


"Our findings contribute further understanding of the biology of psychiatric and neurological diseases and whether autoantibodies detected in a subgroup of patients can trigger .


"Further research will reveal whether these antibodies are the mark of a clinically relevant subset of patients and, if so, whether immunosuppressive therapies can effectively treat children with these debilitating illnesses."



Medical Xpress on facebook


Related Stories


Antibodies to brain proteins may trigger psychosis


date Mar 05, 2015

Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop.



Adolescents exhibiting symptoms of mental disorders should be asked about hallucinations


date Jan 22, 2015

Visual distortions and hallucinations related to an elevated risk of psychosis are linked to self-destructive thought processes among adolescents with psychological symptoms, according to a recent Finnish study. Early indications ...



Dopamine and hippocampus


date Apr 03, 2014

Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in ...



Researchers find epigenetic tie to neuropsychiatric disorders


date Jul 21, 2014

Dysfunction in dopamine signaling profoundly changes the activity level of about 2,000 genes in the brain's prefrontal cortex and may be an underlying cause of certain complex neuropsychiatric disorders, ...



Altered dopamine signaling a clue to autism


date Jan 30, 2015

Newly discovered genetic variations linked to autism spectrum disorder (ASD) disrupt the function of the dopamine transporter, suggesting that altered dopamine signaling contributes to this common developmental condition, ...





Recommended for you



Teenagers more inclined to repeat 'risky' behaviour


date 1 hour ago

School-age teenagers who have previously engaged in risky online behaviour are much more likely than young adults to repeat such behaviour in the future, according to a new study by Plymouth University.




Symmetry leads to lack of attention


date 1 hour ago

New research has found humans are likely to underestimate the amount of detail in symmetrical compared to random patterns.




Smartphone app could change how depression is diagnosed


date 1 hour ago

It's common to hear complaints about our near-constant connection to our smart phones, but UConn researchers believe they can use the ubiquity of these devices to better screen for depression.



Blueberries show promise as treatment for post-traumatic stress disorder


date 2 hours ago

Up to 8 percent of people in the U.S. suffer from post-traumatic stress disorder (PTSD) as the result of witnessing or being the victim of a traumatic event. People with PTSD have been in a situation in which they were at ...




Impact of domestic violence on women's mental health


date 6 hours ago

In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of ...




Scientists find clues into cognitive dysfunction in chronic fatigue syndrome


date 10 hours ago

Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue ...




User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here to reset your password.

Sign in to get notified via email when new comments are made.











Credit: Robert Kraft/public domain


A world first study revealing the presence of two antibodies in a sub-group of children experiencing their first episode of psychosis affirms a longstanding recognition that auto-immune disorders play a significant role in psychiatric illness.



Antibodies defend the body against bacterial, viral, and other invaders but sometimes the body makes that attack healthy cells. In these cases, develop. These include conditions such as multiple sclerosis (MS), rheumatoid arthritis and Type 1 diabetes.


This 'immune hypothesis' is supported by new work colleagues in the current issue of Biological Psychiatry


Researchers from the Kids Research Institute at the Children's Hospital, Westmead, and the University of Sydney detected antibodies to the dopamine D2 receptor or the N-methyl-D-aspartate (NMDA) glutamate receptor among eight out of 43 children experiencing their first episode of psychosis, but no such antibodies in healthy children.


Both are key neural signaling proteins previously been implicated in psychosis.


"The antibodies we have detected in children having a first episode of acute psychosis suggest there is a distinct subgroup for whom autoimmunity plays a role in their illness," says the University of Sydney's Dr Fabienne Brilot, the senior author on the paper and Head of the Neuroimmunology Group at The Children's Hospital at Westmead in Sydney.


"The finding suggests that better interventions are possible, providing hope that major disability can be prevented for the subset of children experiencing acute psychosis with antibodies," Brilot adds.


Dopamine is a chemical messenger aiding the transmission of signals in the brain and other areas of the body. Regulating its actions plays a crucial role in mental and physical health.


Dopamine acts on receptors tailored specifically for it. The dopamine-2 receptor (D2R) is one of five subtypes of mammalian dopamine. Increasing knowledge of the roles of dopamine receptor subtypes raises the hope that more selective drugs will be developed.


Abnormalities in dopaminergic neurotransmission play a key role in the pathogenesis of psychosis. Many drugs affect dopamine transmission directly by either blocking or stimulating its receptors.


Many antipsychotics show varying affinities for the different but blockade of the dopamine-2 receptor (D2R) specifically has proved to be indispensable in the clinical management of psychosis.


While less well established than , it is also likely that glutamatergic dysfunction also plays a role in psychotic disease.


This suggests that specific pathologies and processes affecting D2R and the glutamatergic N-methyl-D-aspartate receptor (NMDAR) could define biological subgroups and may be involved in the pathogenesis of and other psychiatric illnesses such as schizophrenia.


"There is a pressing need in psychiatry to establish biologically based disease subtypes, which might allow for more specific diagnosis and effective intervention," says Dr Brilot.


"Our findings contribute further understanding of the biology of psychiatric and neurological diseases and whether autoantibodies detected in a subgroup of patients can trigger .


"Further research will reveal whether these antibodies are the mark of a clinically relevant subset of patients and, if so, whether immunosuppressive therapies can effectively treat children with these debilitating illnesses."



Medical Xpress on facebook


Related Stories


Antibodies to brain proteins may trigger psychosis


date Mar 05, 2015

Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop.



Adolescents exhibiting symptoms of mental disorders should be asked about hallucinations


date Jan 22, 2015

Visual distortions and hallucinations related to an elevated risk of psychosis are linked to self-destructive thought processes among adolescents with psychological symptoms, according to a recent Finnish study. Early indications ...



Dopamine and hippocampus


date Apr 03, 2014

Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in ...



Researchers find epigenetic tie to neuropsychiatric disorders


date Jul 21, 2014

Dysfunction in dopamine signaling profoundly changes the activity level of about 2,000 genes in the brain's prefrontal cortex and may be an underlying cause of certain complex neuropsychiatric disorders, ...



Altered dopamine signaling a clue to autism


date Jan 30, 2015

Newly discovered genetic variations linked to autism spectrum disorder (ASD) disrupt the function of the dopamine transporter, suggesting that altered dopamine signaling contributes to this common developmental condition, ...





Recommended for you



Teenagers more inclined to repeat 'risky' behaviour


date 1 hour ago

School-age teenagers who have previously engaged in risky online behaviour are much more likely than young adults to repeat such behaviour in the future, according to a new study by Plymouth University.




Symmetry leads to lack of attention


date 1 hour ago

New research has found humans are likely to underestimate the amount of detail in symmetrical compared to random patterns.




Smartphone app could change how depression is diagnosed


date 1 hour ago

It's common to hear complaints about our near-constant connection to our smart phones, but UConn researchers believe they can use the ubiquity of these devices to better screen for depression.



Blueberries show promise as treatment for post-traumatic stress disorder


date 2 hours ago

Up to 8 percent of people in the U.S. suffer from post-traumatic stress disorder (PTSD) as the result of witnessing or being the victim of a traumatic event. People with PTSD have been in a situation in which they were at ...




Impact of domestic violence on women's mental health


date 6 hours ago

In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of mental health problems such as depression and psychotic symptoms. These are the findings of ...




Scientists find clues into cognitive dysfunction in chronic fatigue syndrome


date 10 hours ago

Scientists at Columbia University's Mailman School of Public Health have identified a unique pattern of immune molecules in the cerebrospinal fluid of people with myalgic encephalomyelitis/chronic fatigue ...




User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here

to reset your password.


Sign in to get notified via email when new comments are made.











Categories:

0 comments:

Post a Comment